Alpha Tau Medical Ltd (DRTS) — Financial statements
Income statement, balance sheet, and cash flow for Alpha Tau Medical Ltd — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 1↑11.8% | 1↑2.6% | 1↑9.7% | 0.98↑26.2% | 0.78 | |
| Gross Profit | -1↓11.8% | -1↓2.6% | -1↓9.7% | -0.98↓26.2% | -0.78 | |
| Operating Expenses | ||||||
| R&D Expenses | 31↑14.1% | 27↑2.3% | 26↑26.5% | 21↑82.5% | 11 | |
| General & Administrative Expenses | 8↑25.3% | 7↓9.0% | 7↓28.6% | 10↑452.0% | 2 | |
| Selling & Marketing Expenses | 2↑49.2% | 1↓35.2% | 2↑97.5% | 0.97↑102.1% | 0.48 | |
| SG&A Expenses | 10↑29.1% | 8↓14.4% | 9↓17.7% | 11↑380.0% | 2 | |
| Other Expenses | 0.00 | 0.00↑100.0% | -1 | 0.00 | 0.00 | |
| Operating Expenses | 41↑17.5% | 35↑1.0% | 35↑7.7% | 32↑133.0% | 14 | |
| Total Costs & Expenses | 42↑217.3% | -36↓1.0% | -36↓211.0% | 32↑133.0% | 14 | |
| Operating Results | ||||||
| Operating Income | -42↓17.3% | -36↓201.0% | 36↑211.0% | -32↓133.0% | -14 | |
| Depreciation & Amortization | 1↑11.8% | 1↑2.6% | 1↑9.7% | 0.98↑26.2% | 0.78 | |
| EBITDA | -41↓35.5% | -30↓8.1% | -28↑14.4% | -33↓147.8% | -13 | |
| EBIT | -42↓34.7% | -31↓7.9% | -29↑13.7% | -34↓141.0% | -14 | |
| Interest & Other Income | ||||||
| Net Interest Income | 3↓13.1% | 4↓16.6% | 5↑22357.1% | 0.02↑100.2% | -13 | |
| Interest Income | 4↓10.3% | 4↓10.1% | 5↑165.6% | 2↑748.3% | 0.21 | |
| Interest Expense | 0.42↑21.8% | 0.34↑782.1% | 0.04↓97.8% | 2↓86.7% | 13 | |
| Non-Operating Income | 0.00↑100.0% | -5 | 0.00↓100.0% | 2↑688.6% | 0.20 | |
| Other Income / Expenses | -0.22↓105.1% | 4↓34.3% | 7↑507.2% | -2↑88.1% | -13 | |
| Income Before Tax | -43↓33.9% | -32↓8.9% | -29↑13.6% | -34↓23.8% | -27 | |
| Income Tax Expense | 0.12↑1916.7% | 0.01↓62.5% | 0.02↓20.0% | 0.02↑185.7% | 0.01 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -43↓34.3% | -32↓8.9% | -29↑13.6% | -34↓23.8% | -27 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -43↓34.3% | -32↓8.9% | -29↑13.6% | -34↓23.8% | -27 | |
| Bottom-Line Net Income | -43↓34.3% | -32↓8.9% | -29↑13.6% | -34↓23.8% | -27 | |
| EPS (Basic) | -0.53↓17.8% | -0.45↓7.1% | -0.42↑20.8% | -0.53↑20.9% | -0.67 | |
| EPS (Diluted) | -0.53↓17.8% | -0.45↓7.1% | -0.42↑20.8% | -0.53↑20.9% | -0.67 | |
| Weighted Average Shares | 81↑15.2% | 70↑0.8% | 69↑9.2% | 64↑56.8% | 41 | |
| Weighted Average Diluted Shares | 81↑15.2% | 70↑0.8% | 69↑9.2% | 64↑56.8% | 41 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.